|
GB2213058B
(en)
*
|
1987-12-03 |
1991-07-17 |
Reckitt & Colmann Prod Ltd |
Compositions comprising buprenorphine and naltrexone for treatment of opiate addicts
|
|
GB8728294D0
(en)
*
|
1987-12-03 |
1988-01-06 |
Reckitt & Colmann Prod Ltd |
Treatment compositions
|
|
US5236714A
(en)
*
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
|
US5272149A
(en)
*
|
1992-05-05 |
1993-12-21 |
Stalling Reginald W |
Symptom controlled receptor substitution for addiction withdrawl
|
|
US5512578A
(en)
*
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
DE19652188C2
(de)
*
|
1996-12-16 |
2002-02-14 |
Lohmann Therapie Syst Lts |
Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
|
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
IL134796A0
(en)
*
|
1997-09-04 |
2001-04-30 |
Novoneuron Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
PT1041987E
(pt)
*
|
1997-12-22 |
2006-07-31 |
Euro Celtique Sa |
Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
|
|
JP2001526229A
(ja)
*
|
1997-12-22 |
2001-12-18 |
ユーロ−セルティーク，エス．エイ． |
オピオイド投薬剤形の乱用を防止する方法
|
|
EP0984276A4
(en)
*
|
1998-02-16 |
2003-08-27 |
Inst Physical & Chem Res |
CAPILLARY CASSETTE AND METHOD FOR THE PRODUCTION THEREOF
|
|
US6007841A
(en)
*
|
1998-03-13 |
1999-12-28 |
Algos Pharmaceutical Corporation |
Analgesic composition and method for treating pain
|
|
US7087215B2
(en)
*
|
1998-12-21 |
2006-08-08 |
Generex Pharmaceuticals Incorporated |
Methods of administering and enhancing absorption of pharmaceutical agents
|
|
US6849263B2
(en)
*
|
1998-12-21 |
2005-02-01 |
Generex Pharmaceutical Incorporated |
Pharmaceutical compositions for buccal delivery of pain relief medications
|
|
PT1212061E
(pt)
*
|
1999-08-27 |
2005-01-31 |
Southern Res Inst |
Composicoes injectaveis de microparticulas de buprenorfina e suas utilizacoes
|
|
RU2147880C1
(ru)
*
|
1999-11-10 |
2000-04-27 |
Мамренко Валерий Русланович |
Лекарственное средство для лечения пациентов с хроническим алкоголизмом и способ их лечения
|
|
AR031682A1
(es)
|
1999-11-19 |
2003-10-01 |
Reckitt Benckiser Helthcare Uk |
Composiciones farmaceuticas
|
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
SI2517710T1
(sl)
*
|
2000-02-08 |
2015-07-31 |
Euro-Celtique S.A. |
Oralne formulacije opioidnih agonistov, varne pred zlorabo
|
|
US20030065002A1
(en)
|
2001-05-11 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant controlled-release opioid dosage form
|
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
|
US20030022909A1
(en)
*
|
2001-06-05 |
2003-01-30 |
University Of Chicago |
Use of methylnaltrexone to treat immune suppression
|
|
DK1404331T3
(da)
*
|
2001-07-06 |
2008-01-28 |
Penwest Pharmaceuticals Co |
Sustained release-formuleringer af oxymorphon
|
|
JP2005515966A
(ja)
*
|
2001-07-06 |
2005-06-02 |
エンドー ファーマシューティカルズ， インコーポレイティド |
鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
|
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
DK1416842T3
(da)
*
|
2001-07-18 |
2009-03-16 |
Euro Celtique Sa |
Farmaceutiske kombinationer af oxycodon og naloxon
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
WO2003013525A1
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Opioid agonist formulations with releasable and sequestered antagonist
|
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20030157168A1
(en)
*
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
|
US20030091635A1
(en)
*
|
2001-09-26 |
2003-05-15 |
Baichwal Anand R. |
Opioid formulations having reduced potential for abuse
|
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
|
US20050245483A1
(en)
|
2002-04-05 |
2005-11-03 |
Bianca Brogmann |
Matrix for sustained, invariant and independent release of active compounds
|
|
CA2487577C
(en)
*
|
2002-05-31 |
2014-11-18 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
|
SI1551372T1
(en)
|
2002-09-20 |
2018-08-31 |
Alpharma Pharmaceuticals Llc |
SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
|
|
JP2006520392A
(ja)
*
|
2003-03-13 |
2006-09-07 |
コントロールド・ケミカルズ・インコーポレーテッド |
薬物の乱用可能性を低下させ且つ作用持続時間を延長する化合物および方法
|
|
AU2004228017C1
(en)
*
|
2003-03-31 |
2010-06-03 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of dopamine agonist
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
CA2569958C
(en)
|
2004-06-12 |
2016-03-22 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
|
EP1702558A1
(en)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
US7568409B2
(en)
*
|
2005-03-30 |
2009-08-04 |
Federal-Mogul World Wide, Inc |
Hybrid orbiting spindle for shaping non-circular holes
|
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
|
SI2034975T1
(sl)
*
|
2006-06-19 |
2012-07-31 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
|
DK2101740T3
(da)
|
2006-12-04 |
2013-11-18 |
Orexo Ab |
Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider
|
|
US20080199407A1
(en)
|
2007-02-15 |
2008-08-21 |
Slater Kenneth C |
Drug Detoxification Protocol Using Microdosing
|
|
WO2008105920A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Collegium Pharmaceutical, Inc. |
Antihistamine combination
|
|
GB2447014A
(en)
|
2007-03-01 |
2008-09-03 |
Reckitt Benckiser Healthcare |
Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
|
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
|
CA2709992A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Abuse resistant pharmaceutical compositions of opiod agonists
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
|
JP5406288B2
(ja)
*
|
2008-07-07 |
2014-02-05 |
ユーロ−セルティーク エス．エイ． |
尿閉を治療するためのオピオイド拮抗薬の使用
|
|
ME03298B
(me)
|
2009-03-10 |
2019-07-20 |
Euro Celtique Sa |
Farmaceutske kombinacije sa trenutnim oslobađanjem које obuhvataju oksikodon i nalokson
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US9394294B2
(en)
|
2010-05-11 |
2016-07-19 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US8637648B1
(en)
|
2010-06-22 |
2014-01-28 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
US8741891B1
(en)
|
2010-06-22 |
2014-06-03 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
|
US9586954B2
(en)
|
2010-06-22 |
2017-03-07 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
RU2586296C2
(ru)
|
2010-07-23 |
2016-06-10 |
Демеркс, Инк. |
Композиции норибогаина
|
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
US9617274B1
(en)
|
2011-08-26 |
2017-04-11 |
Demerx, Inc. |
Synthetic noribogaine
|
|
ME02153B
(me)
|
2011-09-19 |
2015-10-20 |
Orexo Ab |
Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
|
|
CA2855994A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
US9211293B2
(en)
*
|
2011-12-15 |
2015-12-15 |
Alkermes Pharma Ireland Limited |
Opioid agonist antagonist combinations
|
|
US9150584B2
(en)
|
2012-01-25 |
2015-10-06 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
WO2013112673A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Synthetic voacangine
|
|
US9045481B2
(en)
|
2012-12-20 |
2015-06-02 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8940728B2
(en)
|
2012-12-20 |
2015-01-27 |
Demerx, Inc. |
Substituted noribogaine
|
|
CA2896133A1
(en)
|
2012-12-20 |
2014-06-26 |
Demerx, Inc. |
Substituted noribogaine
|
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
|
WO2015195673A2
(en)
|
2014-06-18 |
2015-12-23 |
Demerx, Inc. |
Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
|
|
MX2018002839A
(es)
*
|
2015-09-09 |
2018-09-12 |
Biodelivery Sciences Int Inc |
Metodos de transicion segura de un sujeto a buprenorfina.
|
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
|
WO2019099679A1
(en)
|
2017-11-15 |
2019-05-23 |
The Regents Of The University Of California |
Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain
|